Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 12.30 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Pfenex Inc | PFNX | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.22 | -1.76% | 12.30 | 12.80 | 12.09 | 12.79 | 12.52 | 23:59:44 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,023 | 373,608 | $ 12.43 | $ 4,642,398 | 348,105 | 3.40 - 13.95 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:37 | 13,818 | $ 12.30 | USD |
Pfenex Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 389.61M | 31.68M | $ -39.59M | -1.42 | -90.80 | 30.90M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 535.75k | $ - | 0.00% | - | - |
Pfenex News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PFNX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.44 | 13.95 | 12.09 | 12.86 | 357,718 | -0.14 | -1.13% |
| 1 Month | 12.39 | 13.95 | 10.54 | 12.19 | 331,545 | -0.09 | -0.73% |
| 3 Months | 9.74 | 13.95 | 8.413 | 11.18 | 296,110 | 2.56 | 26.28% |
| 6 Months | 5.93 | 13.95 | 5.60 | 9.56 | 298,535 | 6.37 | 107.42% |
| 1 Year | 3.90 | 13.95 | 3.40 | 8.32 | 234,964 | 8.40 | 215.38% |
| 3 Years | 9.03 | 13.95 | 2.07 | 6.35 | 172,388 | 3.27 | 36.21% |
| 5 Years | 6.78 | 24.41 | 2.07 | 8.51 | 146,581 | 5.52 | 81.42% |
Pfenex Description
| Pfenex Inc is a clinical-stage biotechnology company involved in the development of protein production and bioanalytic technology. The biosimilars portfolio include PF582, for the treatment of patients with retinal diseases; PF530, designed to treat patients with multiple sclerosis; and PF708, to treat osteoporosis patients at high risk of fractures. Its vaccine portfolio consists of Px563L, a novel anthrax vaccine candidate to meet U.S. government demand, funded by the U.S. Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority. |
